Biocryst Pharmaceuticals Inc.

BCRX·NASDAQ·$8.47Share Price as of 11/2·$2BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/05/26 10-QQ1 ended 03/31/2605/06/26 10-KFY 202502/26/26 10-QQ3 ended 09/30/2511/04/25 10-QQ2 ended 06/30/2508/05/25

Disclosures

8-KCurrent report08/05/26 8-K/ACurrent report (amended)08/04/26 8-KCurrent report06/29/26 8-KCurrent report06/12/26 8-KCurrent report05/06/26

Prospectuses and Registrations

S-8Registration of securities for employees08/05/26 424B3Prospectus12/18/25 S-4/ARegistration (business combination, amended)12/15/25 S-4Registration (business combination)11/20/25 S-8Registration of securities for employees08/12/25

Proxies

DEF 14ADefinitive proxy04/23/26 DEFA14AAdditional proxy materials04/23/26 DEF 14ADefinitive proxy04/24/25 DEFA14AAdditional proxy materials04/24/25 DEF 14ADefinitive proxy04/25/24

Ownership

Form 4Insider transaction09/02/26 Form 4Insider transaction09/02/26 Form 4Insider transaction09/02/26 Form 4Insider transaction09/02/26 Form 4Insider transaction09/02/26

Other

ARSAnnual report to shareholders04/23/26 EFFECTRequest for effectiveness12/18/25 CORRESPCorrespondence with the SEC12/16/25 42542512/03/25 42542510/14/25